Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type in Texas
Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in Texas
| Provider | Medicare | Services |
|---|---|---|
| Texas Molecular Diagnostics... | $28.63 | 5.3K |
| American Premier Labs | $28.64 | 3.4K |
| Curie Dx Laboratory Llc | $28.64 | 260 |
| Elite Clinical Laboratory, Inc | $28.64 | 167 |
| New Schryver Llc | $28.64 | 81 |
| Thomas, Flavia D.O. | $28.64 | 39 |
Texas Pricing in Context
In Texas, CPT code 87503 (Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type) carries an average Medicare payment of $28.64 — 0% below the national benchmark of $28.64. 9 providers across the state submitted claims for this procedure in 2023, performing 9.3K total services. Individual payments in TX ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in Texas is $30.65, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Texas sits below the national Medicare average, commercial rates in the state may also run lower than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in Texas lands near $65.87, with self-pay cash prices typically around $29.91. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type cost in Texas?
The average Medicare payment for Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type in Texas is $28.64, which is 0% below the national average of $28.64. Providers in TX typically bill $30.65 for this procedure.
What does Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type cost with insurance in Texas?
With commercial insurance in Texas, Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type costs an estimated $65.87. Without insurance, the estimated cash price is $29.91. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type in Texas?
9 providers in Texas billed Medicare for Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type in 2023, performing 9.3K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type cheaper in Texas than the national average?
Yes — Detection Test By Nucleic Acid For Multiple Types Influenza Virus, Each Additional Influenza Virus Type Or Sub-Type costs 0% below the national average in Texas. The state average Medicare payment is $28.64 compared to $28.64 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.